K. Li

发表

Genome-wide analysis of three-way interplay among gene expression, cancer cell invasion and anti-cancer compound sensitivity

Ker-Chau Li, Shin-sheng Yuan, Hsuan-Yu Chen, 2013, BMC Medicine.

Genome-wide coexpression dynamics: Theory and application

Ker-Chau Li, K. Li, Ker-Chau Li, 2002, Proceedings of the National Academy of Sciences of the United States of America.

Analysis of spatial-temporal gene expression patterns reveals dynamics and regionalization in developing mouse brain

Ker-Chau Li, C. Yeang, Zhen-Xian Niou, 2016, Scientific Reports.

Regression Analysis Under Link Violation

Ker-Chau Li, N. Duan, K. Li, 1989 .

Sliced Inverse Regression

Ker-Chau Li, K. Li, 2014 .

CAN SIR BE AS POPULAR AS MULTIPLE LINEAR REGRESSION

Chun-Houh Chen, Ker-Chau Li, Chun-Houh Chen, 2003 .

Nonlinear confounding in high-dimensional regression

Ker-Chau Li, K. Li, Ker-Chau Li, 1997 .

Exploring regression structure with graphics

S. Weisberg, Ker-Chau Li, Sally C. Morton, 1993 .

Measurement Error Regression with Unknown Link: Dimension Reduction and Data Visualization

Raymond J. Carroll, Ker-Chau Li, R. Carroll, 1992 .

On Principal Hessian Directions for Data Visualization and Dimension Reduction: Another Application of Stein's Lemma

Ker-Chau Li, K. Li, Ker-Chau Li, 1992 .

Sliced Inverse Regression for Dimension Reduction

Ker-Chau Li, K. Li, Ker-Chau Li, 1991 .

MicroRNA signature predicts survival and relapse in lung cancer.

Sung-Liang Yu, Ching-Cheng Chiang, Ker-Chau Li, 2008, Cancer cell.

The M1/M2 spectrum and plasticity of malignant pleural effusion-macrophage in advanced lung cancer

Ker-Chau Li, G. Chang, Hsiang-Yuan Yeh, 2020, Cancer Immunology, Immunotherapy.

Subclassification of prostate cancer circulating tumor cells by nuclear size reveals very small nuclear circulating tumor cells in patients with visceral metastases

Shuang Hou, Hsian-Rong Tseng, Ker-Chau Li, 2015, Cancer.

Subclassification of prostate cancer circulating tumor cells (CTCs) by nuclear size reveals very-small nuclear CTCs in patients with visceral metastases.

Ker-Chau Li, H. Tseng, L. Chung, 2015 .

The index patient and samples

Huanming Yang, Jun Wang, Xiuqing Zhang, 2015 .

EGFR-activating mutations, DNA copy number abundance of ErbB family, and prognosis in lung adenocarcinoma

Ker-Chau Li, Hsuan-Yu Chen, Sung-Liang Yu, 2016, Oncotarget.

Pretreatment epidermal growth factor receptor (EGFR) T790M mutation predicts shorter EGFR tyrosine kinase inhibitor response duration in patients with non-small-cell lung cancer.

Sung-Liang Yu, Ker-Chau Li, Min-Liang Kuo, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clustered genomic alterations in chromosome 7p dictate outcomes and targeted treatment responses of lung adenocarcinoma with EGFR-activating mutations.

Jeremy J. W. Chen, Ker-Chau Li, Y. Lai, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.